OpenURL Connection Search

Select item for more details and to access through your institution.

RANKL-Induced Btn2a2 – A T Cell Immunomodulatory Molecule – During Osteoclast Differentiation Fine-Tunes Bone Resorption.
Published in:
Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.685060
By:
- Frech, Michael;
- Schuster, Gregor;
- Andes, Fabian T.;
- Schett, Georg;
- Zaiss, Mario M.;
- Sarter, Kerstin
Publication type:
Article
JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function.
Published in:
Science Translational Medicine, 2020, v. 12, n. 530, p. 1, doi. 10.1126/scitranslmed.aay4447
By:
- Adam, Susanne;
- Simon, Nils;
- Steffen, Ulrike;
- Andes, Fabian T.;
- Scholtysek, Carina;
- Müller, Dorothea I. H.;
- Weidner, Daniela;
- Andreev, Darja;
- Kleyer, Arnd;
- Culemann, Stephan;
- Hahn, Madelaine;
- Schett, Georg;
- Krönke, Gerhard;
- Frey, Silke;
- Hueber, Axel J.
Publication type:
Article
IgA subclasses have different effector functions associated with distinct glycosylation profiles.
Published in:
Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-13992-8
By:
- Steffen, Ulrike;
- Koeleman, Carolien A.;
- Sokolova, Maria V.;
- Bang, Holger;
- Kleyer, Arnd;
- Rech, Jürgen;
- Unterweger, Harald;
- Schicht, Martin;
- Garreis, Fabian;
- Hahn, Jonas;
- Andes, Fabian T.;
- Hartmann, Fabian;
- Hahn, Madelaine;
- Mahajan, Aparna;
- Paulsen, Friedrich;
- Hoffmann, Markus;
- Lochnit, Günter;
- Muñoz, Luis E.;
- Wuhrer, Manfred;
- Falck, David
Publication type:
Article

Found: 3

RANKL-Induced Btn2a2 – A T Cell Immunomodulatory Molecule – During Osteoclast Differentiation Fine-Tunes Bone Resorption.

JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function.

IgA subclasses have different effector functions associated with distinct glycosylation profiles.